iLab performs quantitative RT-PCR-analyses, quantitative antibody analyses, quantitative neutralized antibody analyses, biochemistry analyses and genetic analyses. iLab has a research team consisting of three Ph.D. in Chemistry and Clinical Microbiology, one M.D. Ph.Lic., consultant surgeon, one Master of Science in Biotechnology and one Bachelor in Nursing. iLab is co-owned by Gynius Plus AB, Svea Vaccin AB and iDr Medical Consulting AB and performs analyses on behalf of iDr/Svea patients. iLab aims at being one of Sweden's leading research laboratories.